Akram Dastagir, MD
Neurology · Golden Valley, MNNPI 1952616690
Payments from drug & device makers
Across 289 payments — averaging $888.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$70K
- TG Therapeutics, Inc.$65K
- EMD Serono, Inc.$46K
- Biogen$28K
- AbbVie$18K
- E.r. Squibb & Sons, L.L.C.$10K
- plus $20K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 15 | $70,262 |
| TG Therapeutics, Inc. | 49 | $64,840 |
| EMD Serono, Inc. | 52 | $45,963 |
| Biogen | 32 | $27,842 |
| AbbVie | 23 | $17,547 |
| E.r. Squibb & Sons, L.L.C. | 10 | $9,864 |
| Amgen(2 entities) | 14 | $8,946 |
| Johnson & Johnson | 8 | $4,682 |
| Bristol Myers Squibb | 24 | $2,649 |
| Genentech USA, Inc. | 1 | $2,050 |
| Janssen Scientific Affairs, LLC | 1 | $1,020 |
| Lilly USA, LLC | 6 | $110 |
| Lundbeck LLC | 6 | $88 |
| Catalyst Pharmaceuticals, Inc. | 4 | $84 |
| Amneal Pharmaceuticals LLC | 4 | $81 |
| Acadia Pharmaceuticals Inc | 4 | $63 |
| Teva Pharmaceuticals USA, Inc. | 4 | $62 |
| Sanofi | 2 | $53 |
| Neurelis, Inc. | 3 | $41 |
| Upsher-smith Laboratories LLC | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Eisai Inc. | 2 | $38 |
| UCB, Inc. | 2 | $35 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Mylan Specialty L.p. | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 2 | $28 |
| SK Life Science, Inc. | 2 | $28 |
| Pfizer | 2 | $27 |
| United Imaging Healthcare North America LLC | 1 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Averitas Pharma Inc. | 1 | $21 |
| Greenwich Biosciences, Inc. | 1 | $19 |
| Octapharma USA, Inc. | 1 | $16 |
| CSL Behring | 1 | $16 |
| Argenx US, Inc. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$256,719 in reported general payments places this provider in the 90th percentile of 434 neurology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Golden Valley
- Jonathan CalkwoodGolden Valley$4.9M
- Jessica StulcGolden Valley$3.3M
- Jessica HeiringGolden Valley$561K
- Joanne RoginGolden Valley$433K
- Irfan AltafullahGolden Valley$387K
- Brent BerryGolden Valley$141K
- Sean PittockRochester$3.2M
- Miguel Paz SoldanRochester$2.4M
- Ryan TownleyRochester$2M
- Rajiv AggarwalBurnsville$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.